My research is primarily focused on autophagy and selective autophagy (including nucleophagy and mitophagy) and their mechanistic roles in cell fate decisions, metabolic regulation, cancer biology, toxicology, and host–pathogen interactions. I have extensive expertise in dissecting PI3K/AKT/mTOR-regulated autophagy pathways, lysosomal dynamics, mitochondrial dysfunction, and crosstalk between autophagy and apoptosis using in-vitro and in-vivo models. My work integrates cell culture–based molecular biology, clinical biochemistry, insect and Drosophila models, natural bioactive compounds, and nanomaterial-based interventions, with a strong emphasis on mechanistic validation using biomarkers such as LC3, Beclin-1, ATG8, caspases, and BCL-2 family proteins.
My research is primarily focused on autophagy and selective autophagy (including nucleophagy and mitophagy) and their mechanistic roles in cell fate decisions, metabolic regulation, cancer biology, toxicology, and host–pathogen interactions. I have extensive expertise in dissecting PI3K/AKT/mTOR-regulated autophagy pathways, lysosomal dynamics, mitochondrial dysfunction, and crosstalk between autophagy and apoptosis using in-vitro and in-vivo models. My work integrates cell culture–based molecular biology, clinical biochemistry, insect and Drosophila models, natural bioactive compounds, and nanomaterial-based interventions, with a strong emphasis on mechanistic validation using biomarkers such as LC3, Beclin-1, ATG8, caspases, and BCL-2 family proteins.